Tenormin (Atenolol)
Brand Names: Tenormin
Methodology & AI Transparency ⓘ
Tenormin (Atenolol) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Formulated with active moiety Atenolol (cross-referenced at /meds/atenolol) and registered by Upsher-Smith Laboratories, LLC, Tenormin operates as a prescription brand-name beta-adrenergic blocker therapy (RxNorm 197380-B24979245; NDC 24979-245, 24979-244).
- 2 Real-world patient consensus: Commercial Tenormin monograph (50 mg/1 Tablet) cross-indexed with generic Atenolol for therapeutic equivalence review.
- 3 Typical cash cost range: 30-day cash pricing ranges from $5.33 on Cost Plus Drugs to $34.50 walk-in retail (NADAC $12.7781/unit).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Tenormin (Atenolol): dizziness (6.2%), headache (6.5%), fatigue (5.9%).
Ask our AI Specialists anything about Tenormin (Atenolol)
Tenormin (Atenolol) Mechanism, CYP450 Pathways & DailyMed Monograph
Formulated with active moiety Atenolol (cross-referenced at /meds/atenolol) and registered by Upsher-Smith Laboratories, LLC, Tenormin operates as a prescription brand-name beta-adrenergic blocker therapy (RxNorm 197380-B24979245; NDC 24979-245, 24979-244). Under 2025-12-26 FDA labeling for 50 mg/1 Tablet; 25 mg/1 Tablet, Hypertension Atenolol tablets are indicated for the treatment of hypertension, to lower blood pressure.
Bioactive Atenolol within Tenormin governs beta-adrenergic blocker target modulation with class-characteristic hepatorenal disposition. Commercialized across 50 mg/1 Tablet; 25 mg/1 Tablet (registered by Upsher-Smith Laboratories, LLC, SPL 2025-12-26), Tenormin combines branded dosage-form consistency (NDC 24979-245, 24979-244) with transparent cash-pay comparisons spanning $5.33 to $34.50.
With Mean elimination half-life of 4 to 16 hours across adult Tenormin (Atenolol) dosing residence kinetics and Oral fraction absorbed ranges from 45% to 57% (Tenormin (Atenolol) 50) bioavailability, Tenormin (Atenolol) undergoes dual hepatorenal clearance pathway combining glucuronidation and urinary filtration of tenormin (atenolol) and establishes therapeutic activity over oral tmax achieved within 2 to 3 hours following tenormin (atenolol) ingestion.
Standard adult regimens span 50 mg/1 Tablet, 25 mg/1 Tablet, 100 mg/1 Tablet, 25mg Tablet. Prescribers screen specifically against previous anaphylactoid or exfoliative reaction attributed to tenormin (atenolol); clinical scenarios where beta-adrenergic blocker exposure from tenormin (atenolol) poses unacceptable risk, while community micro-logs most frequently note headache (6.5% of reports), dizziness (6.2% of reports), fatigue (5.9% of reports).
Electrophysiologic additive QTc lengthening warrants caution when Tenormin (Atenolol) is combined with amiodarone or sotalol.
Staggering Tenormin (Atenolol) apart from antacid or iron products prevents insoluble gastrointestinal complexation.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Previous anaphylactoid or exfoliative reaction attributed to Tenormin (Atenolol)
- Clinical scenarios where beta-adrenergic blocker exposure from Tenormin (Atenolol) poses unacceptable risk
Logged Side-Effect Incidence (5 Reports)
Tenormin (Atenolol) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tenormin (Atenolol))
Human clinical trial evidence for Tenormin (Atenolol) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Tenormin (Atenolol) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $12.7781/unit (~$383.34/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $5.33 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 5 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Tenormin (Atenolol) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Tenormin (Atenolol) RxNorm Concept ID | 197380-B24979245 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $12.7781 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $5.33 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 81.00% Worth It (5 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Tenormin (Atenolol) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Tenormin (Atenolol) integrating DailyMed SPL (2025-12-26), CMS NADAC ($12.7781/unit), and 5 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Tenormin (Atenolol) community threads and patient logs by age, biological sex, dosage, and treatment duration.